Cardiorenal syndrome (CRS) results from complex interaction between heart and kidneys,
inducing simultaneous acute or chronic dysfunction of these organs. Although its incidence …

Background Cardiorenal syndrome (CRS) remains the leading cause of death in
hospitalized patients for all disease entities. Sacubitril/Valsartan (Sac/Val) therapy has been …

Patients with cardiorenal syndrome (CRS) suffer from extremely high levels of morbidity and
mortality. The pathophysiology of the CRS involves inter-related hemodynamic and …

It is difficult to treat cardiorenal syndrome (CRS) in clinical practice, which is the common
reason for the death of patients. This report aimed to describe the effects of …

Heart failure and chronic kidney disease are among the most common comorbidities in the
population. Often, both diseases coexist in the same patient, with a deleterious interaction …

Pathological interplay between the heart and kidneys—also known as cardio-renal
syndrome (CRS)—is frequently encountered in heart failure and is linked to worse prognosis …

Cardiorenal syndromes (CRSs) with bidirectional heart-kidney signaling are increasingly
being recognized for their association with increased morbidity and mortality. In acute CRS …

The heart and kidney are physiologically interconnected. Cardiorenal syndrome (CRS) is a
pathological disorder where acute or chronic dysfunction in one organ may induce …

In the setting of cardiorenal syndrome (s)(CRS), the main pathophysiological triggers of
renal disease progression include increases in renal venous pressure, maladaptive …

Cardiorenal syndrome refers to combined cardiac and renal dysfunction that adversely
impacts both organs and is also associated with severe clinical outcomes. The …